Intervention Review

Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients

  1. Lior H Katz1,*,
  2. Hadar Goldvaser2,
  3. Anat Gafter-Gvili3,
  4. Ran Tur-Kaspa4

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 12 SEP 2012

Assessed as up-to-date: 16 JAN 2012

DOI: 10.1002/14651858.CD008516.pub2


How to Cite

Katz LH, Goldvaser H, Gafter-Gvili A, Tur-Kaspa R. Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD008516. DOI: 10.1002/14651858.CD008516.pub2.

Author Information

  1. 1

    MD Anderdson Cancer Center, Hepatology and Nutrition Department, Houston, Texas, USA

  2. 2

    Beilinson Hospital, Rabin Medical Center, Department of Oncology, Petah Tikva, Israel

  3. 3

    Beilinson Hospital, Rabin Medical Center, Department of Medicine E, Petah Tikva, Israel

  4. 4

    Beilinson Hospital, Rabin Medical Center, Department of Medicine D, Petah Tikva, Israel

*Lior H Katz, Hepatology and Nutrition Department, MD Anderdson Cancer Center, 1515 Holcombe st., Houston, Texas, 77030, USA. liorshlomit@yahoo.com.

Publication History

  1. Publication Status: New
  2. Published Online: 12 SEP 2012

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.